These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9384362)

  • 1. Korea holds firm to biotech expansion.
    Swinbanks D
    Nature; 1997 Nov; 390(6657):213. PubMed ID: 9384362
    [No Abstract]   [Full Text] [Related]  

  • 2. New Zealand launches biotech seed fund.
    Griggs K
    Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
    [No Abstract]   [Full Text] [Related]  

  • 3. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 4. German regions compete for biotech funds.
    Abbott A; Schiermeir Q
    Nature; 1996 Feb; 379(6568):759. PubMed ID: 8587590
    [No Abstract]   [Full Text] [Related]  

  • 5. Plan for $100m boost to Israeli biotech comes under threat.
    Watzman H
    Nature; 1998 Mar; 392(6672):117. PubMed ID: 9515950
    [No Abstract]   [Full Text] [Related]  

  • 6. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 7. French research minister targets IT and biotech.
    McCabe H
    Nature; 2000 May; 405(6783):106. PubMed ID: 10821237
    [No Abstract]   [Full Text] [Related]  

  • 8. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 9. Funding bonanza for astronomy and biotech in Australia.
    Pockley P
    Nature; 2001 Aug; 412(6850):846. PubMed ID: 11528440
    [No Abstract]   [Full Text] [Related]  

  • 10. South Korea continues up ladder of biotech leaders.
    He-suk C
    Biotechnol J; 2006 Sep; 1(9):900-1. PubMed ID: 16986101
    [No Abstract]   [Full Text] [Related]  

  • 11. Translational science: a view from a biotechnology investor.
    Klausner R
    Sci Transl Med; 2010 Jun; 2(34):34ed3. PubMed ID: 20519715
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech boom.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1183-4. PubMed ID: 16151411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. South Korea launches Biotech-2000.
    Swinbanks D
    Nature; 1994 Feb; 367(6462):403. PubMed ID: 8107790
    [No Abstract]   [Full Text] [Related]  

  • 14. Chile launches policy to boost biotech.
    Orellana C
    Nat Biotechnol; 2004 Jan; 22(1):7-8. PubMed ID: 14704689
    [No Abstract]   [Full Text] [Related]  

  • 15. Nuclear safety and biotech boosted in Japan's budget.
    Saegusa A
    Nature; 1999 Dec; 402(6761):451. PubMed ID: 10591194
    [No Abstract]   [Full Text] [Related]  

  • 16. Bayh-Dole: if we knew then what we know now.
    Boettiger S; Bennett AB
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract]   [Full Text] [Related]  

  • 17. Policy. Science policy in Kazakhstan.
    Schweitzer GE
    Science; 2008 Dec; 322(5907):1474-5. PubMed ID: 19056962
    [No Abstract]   [Full Text] [Related]  

  • 18. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 19. Danish biotech centre faces axe.
    Abbott A
    Nature; 2003 Mar; 422(6928):105. PubMed ID: 12634749
    [No Abstract]   [Full Text] [Related]  

  • 20. The promise of South African biotech.
    Akermann B; Kermani F
    Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.